Zweig-DiMenna Associates’s Exelixis EXEL Stock Holding History

Zweig-DiMenna Associates’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-68,923	Closed	-$1.48M	–	154
2018 Q2	$1.48M	Buy	+68,923	New	+$1.43M	0.09%	115

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JIM

Jupiter Investment Management London, United Kingdom $6.26B AUM 13.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Zweig-DiMenna Associates's EXEL Position: Q3 2018 in Review

Zweig-DiMenna Associates sold out of Exelixis (EXEL) in Q3 2018, closing a stake of 68,923 shares — an estimated $1.48M sold.

Zweig-DiMenna Associates first reported a position in EXEL in Q2 2018 and held it in 1 quarter. The position peaked at $1.48M in Q2 2018. 316 funds tracked by Wall St. Rank hold EXEL as of Q3 2018.

Zweig-DiMenna Associates reported no remaining Exelixis position as of Q3 2018 after selling out during the quarter.
Zweig-DiMenna Associates sold 68,923 Exelixis shares in Q3 2018, an estimated $1.48M.
Zweig-DiMenna Associates first reported a position in Exelixis in Q2 2018 and held it in 1 quarter.
Zweig-DiMenna Associates's Exelixis position peaked at $1.48M in Q2 2018.
316 funds tracked by Wall St. Rank held Exelixis as of Q3 2018.

Based on Zweig-DiMenna Associates's 13F filing for Q3 2018, filed 15 Oct 2018.